Financing channel feed

Span­ish VC preps launch for €100M fund with an em­pha­sis on ad­vanced ther­a­pies

Last year

Cor­morant nears the close of fifth pri­vate health­care fund as biotech in­dus­try sees green­er pas­tures

Last year

Al­ly Bridge beefs up 'new gen­er­a­tion' as in­vest­ment firm pass­es 10-year mark

Last year
People

Ex­clu­sive: No­cion rais­es $62M for dif­fer­ent ap­proach to chron­ic cough than Mer­ck, GSK

Last year
Startups

Ex­clu­sive: Backed by MIT’s An­drew Lo, Quan­tile Health rais­es $6M to bol­ster gene ther­a­py ac­cess

Last year
Cell/Gene Tx

Fog­Phar­ma bags $145M, adds Alex­is Borisy to the board 

Last year
Startups

'Sweet spot' of CNS cell ther­a­py: Ke­nai emerges with $82M for Parkin­son's study

Last year
Startups
Cell/Gene Tx

Blos­somHill rais­es $100M in bid to re­peat founder­s' can­cer suc­cess at Turn­ing Point

Last year
Startups

No­vo Hold­ings in­vests in macro­cy­cle start­up Or­bis as once-over­looked mol­e­cules get new in­ter­est

Last year
Startups

Biotech in­dex ris­es above $100 mark for first time in two years

Last year

GV backs hair loss biotech out of UCLA with PhII set for mid-2024

Last year
Startups

UK biotech draws Pfiz­er back­ing in £40.5M Se­ries A for pep­tide-in­spired drugs

Last year
R&D

Fron­tier Med­i­cines rais­es $80M, en­ters clin­ic and eyes po­ten­tial IPO in Q4 or ear­ly 2025

Last year
Startups

Si­mone Song's ORI Cap­i­tal clos­es $260M sec­ond fund af­ter CG On­col­o­gy suc­cess

Last year
Startups

The top 100 ven­ture play­ers in bio­phar­ma to­day. Who's in? What's out?

Last year
Bioregnum

Ex­clu­sive: Dupix­ent in a pill? Start­up In­samo will try to turn block­buster bi­o­log­ics in­to orals

Last year
Startups

Owkin launch­es new start­up to ‘cap­ture laws of bi­ol­o­gy’ with $35M seed round

Last year
Startups
AI

Sofinno­va’s Ma­ha Katabi on re­cent M&A and IPO suc­cess and how deal flow has ‘nev­er been any bet­ter’

Last year
People
Startups

Athos, an au­toim­mune and can­cer biotech, is rais­ing $35M for clin­i­cal tri­als

Last year
Startups

Ap­n­imed, a late-stage sleep ap­nea biotech, eyes IPO in the sec­ond half

Last year
Startups

Car­olyn Bertozzi and Ver­san­t's new biotech breaks cov­er with $94M to use pro­tein de­graders in AD­Cs

Last year
Startups

Freenome rais­es $254M for ear­ly can­cer de­tec­tion tests

Last year
Diagnostics

Two SPAC’d biotechs raise ad­di­tion­al mon­ey as Bi­hua Chen’s blank check clos­es $184M IPO

Last year
Cell/Gene Tx

Lati­go, a pain biotech years in the mak­ing, emerges with $135M on heels of Ver­tex PhI­II suc­cess

Last year
Startups
First page Previous page 18192021222324 Next page Last page
A service from the Financial Times